NDC11 50474098183
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50474-0981-83 | 50474-0981 |
| 50474-981-83 | 50474-981 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RYSTIGGO | ROZANOLIXIZUMAB | UCB, Inc. | 3c0eb8c2-c042-4954-b451-3baa77f5e6d1 | 2026-01-20 | Warnings, Adverse reactions | 50474-981-83 50474-981 50474098183 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.